Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elena Massarotti

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Plos One|July 20, 2018
Use of rheumatology-specific patient navigators to understand and reduce barriers to medication adherence: Analysis of qualitative findingsAlyssa Wohlfahrt, Anarosa Campos, Maura D Iversen, et al.
The Journal of Rheumatology|July 18, 2008
Cost-effectiveness of abatacept in patients with moderately to severely active rheumatoid arthritis and inadequate response to tumor necrosis factor-alpha antagonistsMontserrat Vera-Llonch, Elena Massarotti, Frederick Wolfe, et al.
Arthritis Care & Research|May 22, 2018
Brain Correlates of Continuous Pain in Rheumatoid Arthritis as Measured by Pulsed Arterial Spin LabelingYvonne C Lee, Alexander Fine, Ekaterina Protsenko, et al.
Arthritis Care & Research|June 3, 2017
Can Patient Navigators Improve Adherence to Disease-Modifying Antirheumatic Drugs? Quantitative Findings From a Six-Month Single-Arm Pilot InterventionCandace H Feldman, Alyssa Wohlfahrt, Anarosa Campos, et al.
Journal of the American Academy of Dermatology|April 2, 2013
Association of discoid lupus erythematosus with other clinical manifestations among patients with systemic lupus erythematosusJoseph F Merola, Stephen D Prystowsky, Christina Iversen, et al.
The Journal of Rheumatology|December 3, 2015
Effect of Milnacipran on Pain in Patients with Rheumatoid Arthritis with Widespread Pain: A Randomized Blinded Crossover TrialYvonne C Lee, Elena Massarotti, Robert R Edwards, et al.
Arthritis and Rheumatism|March 30, 2011
Trends in the incidence, demographics, and outcomes of end-stage renal disease due to lupus nephritis in the US from 1995 to 2006Karen H Costenbader, Amrita Desai, Graciela S Alarcón, et al.
Seminars in Arthritis and Rheumatism|March 8, 2024
Reasons for multiple biologic and targeted synthetic DMARD switching and characteristics of treatment refractory rheumatoid arthritisGregory C McDermott, Michael DiIorio, Yumeko Kawano, et al.
Arthritis and Rheumatism|March 10, 2010
Expression of CD44 variant isoforms CD44v3 and CD44v6 is increased on T cells from patients with systemic lupus erythematosus and is correlated with disease activityJosé C Crispín, Brendan T Keenan, Michele D Finnell, et al.
Lupus Science & Medicine|October 9, 2019
Randomised prospective trial to assess the clinical utility of multianalyte assay panel with complement activation products for the diagnosis of SLEDaniel J Wallace, Roberta Vezza Alexander, Tyler O'Malley, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Plos One|July 20, 2018
Use of rheumatology-specific patient navigators to understand and reduce barriers to medication adherence: Analysis of qualitative findingsAlyssa Wohlfahrt, Anarosa Campos, Maura D Iversen, et al.
The Journal of Rheumatology|July 18, 2008
Cost-effectiveness of abatacept in patients with moderately to severely active rheumatoid arthritis and inadequate response to tumor necrosis factor-alpha antagonistsMontserrat Vera-Llonch, Elena Massarotti, Frederick Wolfe, et al.
Arthritis Care & Research|May 22, 2018
Brain Correlates of Continuous Pain in Rheumatoid Arthritis as Measured by Pulsed Arterial Spin LabelingYvonne C Lee, Alexander Fine, Ekaterina Protsenko, et al.
Arthritis Care & Research|June 3, 2017
Can Patient Navigators Improve Adherence to Disease-Modifying Antirheumatic Drugs? Quantitative Findings From a Six-Month Single-Arm Pilot InterventionCandace H Feldman, Alyssa Wohlfahrt, Anarosa Campos, et al.
Journal of the American Academy of Dermatology|April 2, 2013
Association of discoid lupus erythematosus with other clinical manifestations among patients with systemic lupus erythematosusJoseph F Merola, Stephen D Prystowsky, Christina Iversen, et al.
The Journal of Rheumatology|December 3, 2015
Effect of Milnacipran on Pain in Patients with Rheumatoid Arthritis with Widespread Pain: A Randomized Blinded Crossover TrialYvonne C Lee, Elena Massarotti, Robert R Edwards, et al.
Arthritis and Rheumatism|March 30, 2011
Trends in the incidence, demographics, and outcomes of end-stage renal disease due to lupus nephritis in the US from 1995 to 2006Karen H Costenbader, Amrita Desai, Graciela S Alarcón, et al.
Seminars in Arthritis and Rheumatism|March 8, 2024
Reasons for multiple biologic and targeted synthetic DMARD switching and characteristics of treatment refractory rheumatoid arthritisGregory C McDermott, Michael DiIorio, Yumeko Kawano, et al.
Arthritis and Rheumatism|March 10, 2010
Expression of CD44 variant isoforms CD44v3 and CD44v6 is increased on T cells from patients with systemic lupus erythematosus and is correlated with disease activityJosé C Crispín, Brendan T Keenan, Michele D Finnell, et al.
Lupus Science & Medicine|October 9, 2019
Randomised prospective trial to assess the clinical utility of multianalyte assay panel with complement activation products for the diagnosis of SLEDaniel J Wallace, Roberta Vezza Alexander, Tyler O'Malley, et al.
Pageof 4